|Type||Buy / Hold / Sell|
|Year End 30th Jun||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Genus plc is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company operates through three segments: Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers to breed commercial pigs with desirable characteristics for pork production. The Company operates in approximately 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.
Latest News for GNS
Upcoming Events for GNS
Full Year 2022 Genus PLC Earnings Release
Genus PLC Annual Shareholders Meeting
As of Today at 05:27 UTC, shares in Genus are trading at 2,790.00p. This share price information is delayed by 15 minutes.
Shares in Genus last closed at 2,790.00p and the price had moved by -51.1% over the past 365 days. In terms of relative price strength the Genus share price has underperformed the FTSE All Share Index by -51.56% over the past year.
The overall consensus recommendation for Genus is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Genus dividend yield is 1.15% based on the trailing twelve month period.
Last year, Genus paid a total dividend of £0.32, and it currently has a trailing dividend yield of 1.15%. We do not have any data on when Genus is to next pay dividends.
We do not have data on when Genus is to next pay dividends. The historic dividend yield on Genus shares is currently 1.15%.
To buy shares in Genus you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 2,790.00p, shares in Genus had a market capitalisation of £1.84bn.
Here are the trading details for Genus:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: GNS
Based on an overall assessment of its quality, value and momentum Genus is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Genus is 4,343.86p. That is 55.69% above the last closing price of 2,790.00p.
Analysts covering Genus currently have a consensus Earnings Per Share (EPS) forecast of £0.85 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genus. Over the past six months, its share price has underperformed the FTSE All Share Index by -19.78%.
As of the last closing price of 2,790.00p, shares in Genus were trading -20.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Genus PE ratio based on its reported earnings over the past 12 months is 29.61. The shares last closed at 2,790.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Genus' management team is headed by:
- Iain Ferguson - NEC
- Stephen Wilson - CEO
- Alison Henriksen - CFO
- Elena Rice - CSO
- Dan Hartley - GCN
- Angelle Rosata - DHR
- Bill Christianson - OTH
- Jerry Thompson - OTH
- Nate Zwald - OTH
- Jason Chin - NID
- Lysanne Gray - NID
- Lesley Knox - NID
- Lykele van der Broek - NID